HISTOPATHOLOGICAL GRADING OF MENINGIOMA IN ASSOCIATION WITH THE HORMONAL CONTRACEPTIVES’ USAGE
Received 2023-10-12; Accepted 2024-02-19; Published 2024-09-10
DOI:
https://doi.org/10.22452/jummec.vol27no2.20Keywords:
Meningioma, Histopathological Grading, Hormonal contraceptivesAbstract
The high incidence of meningiomas in women indicates the role of female sex hormones in the growth of meningiomas. The use of hormonal contraceptives has been associated with an increased risk of meningiomas. Prior studies have reported an association between hormonal contraceptive use and the expression of certain hormonal receptors in meningioma tissues in which expression of progesterone and estrogen receptors have been associated with histopathological grading of meningiomas. There have been no previous studies about the association between hormonal contraceptive use and the histopathological grading of meningiomas. The aim of this study was to evaluate the association between hormonal contraceptive use and histopathological grading of meningioma. This study
was an analytic cross-sectional study conducted at Mohammad Hoesin General Hospital Palembang and enrolled female meningioma patients with a history of hormonal contraceptive use from January 1st, 2018, to December 31st, 2020. Data were collected from medical records and in person or by phone interview. From 220 meningioma patients, 72 subjects were included in this study with 79.2% were low grade meningioma and 20.8% were high grade meningioma. Among the current users, 66.7% had high-grade meningioma, while 60.0% of combined hormonal contraceptives, and another 60.0% long-term users had high-grade meningioma, respectively. The status of hormonal contraceptive uses (p = 0.038) and the type of hormonal contraceptive (p = 0.001) had a significant association with the histopathological grading of meningioma and became the most significant independent variables according to multivariate logistic regression (p = 0.034; OR: 4.433 and p = 0.001; OR: 9.686) while there was no association between duration of use and histopathological grading of meningioma (p = 0.180). Current users and combination contraceptives (estrogen and progesterone) increased the risk of high-grade meningioma.
Downloads
Downloads
Published
Issue
Section
License
All authors agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0 to allow others to freely access, copy and use research provided the author is correctly attributed, unless otherwise stated. All articles are available online without charge or other barriers to access. However, anyone wishing to reproduce large quantities of an article (250+) should inform the publisher. Any opinion expressed in the articles are those of the authors and do not reflect that of the University of Malaya, 50603 Kuala Lumpur, Malaysia.